IGF1 and cancer: Interestingly, laboratory-based mechanistic studies indicate that protein restriction may protect against cancer due to decreased systemic insulin-like growth factor 1 (IGF-1) signalling and a subsequent downregulation of intracellular mTor activation [11, 12].